About Upperton
Upperton is a Healthcare company based in Nottingham (United Kingdom) founded in 1999, and was acquired by Inflexion in April 2022. Spray drying and drug formulation services for pharmaceuticals are offered. Its website upperton.com draws about 14 thousand monthly visits. Upperton offers products and services including Formulation Development, Clinical Supply, Analytical Development, and Process Scale-Up. Its focus areas include Biopharma Outsourcing, CDMO and Diversified. Its legal entity is 37 UPPERTON RTM COMPANY LIMITED.
Company details
Upperton was founded in 1999 and is based in Nottingham, United Kingdom. Operations focus on the pharmaceutical and biotechnology sectors, where spray drying expertise is applied to develop delivery solutions and formulations. Services encompass pre-formulation screening, excipient selection, spray drying process development, product characterization, stability assessment, and clinical trial manufacturing. Solutions address bioavailability improvement for poorly soluble drugs, particle engineering for pulmonary and nasal routes, protein stability enhancement, and microencapsulation.
- Headquarters Nottingham, United Kingdom
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website upperton.com
- Social LinkedIn
- Acquired by Inflexion (Apr 2022)
- Legal Name 37 Upperton Rtm Company Limited
- Date of Incorporation 25 Jul, 2023
- Jurisdiction HOVE, ENGLAND
Products & Services of Upperton
Upperton offers a comprehensive portfolio of products and services, including Formulation Development, Clinical Supply, Analytical Development, and Process Scale-Up.
Service for creating pharmaceutical formulations for various drug types.
Provides materials for phase I to III clinical trials.
Offers testing and validation for pharmaceutical products.
Supports scaling production for later-stage drug development.
Funding Insights of Upperton
- Total Rounds 1
- Last Round Grant — $2.57M
- First Round $2.57M
(May 2015)
- Investors Count 1
All 1 funding rounds of Upperton with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2015 | $2.57M | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Upperton
Upperton has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Inflexion and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Inflexion is engaged in mid-market private equity investments across Europe. | 1999 | inflexion.com | London, United Kingdom | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Upperton
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Upperton
20 people are tracked at Upperton (10 in leadership, 10 in team).
| Name | Role | Group |
|---|---|---|
Paul Kelsall | Director Of Clinical Manufacturing | Leadership |
Nikki Whitfield | Chief Executive Officer | Leadership |
Jon Austwick | Director Of Quality And Compliance | Leadership |
Ian Lafferty | Chief Technical Officer | Leadership |
Laura Mason | Director Of Pharmaceutical Sciences | Leadership |
Jamie Roberts | Chief Financial Officer | Leadership |
Lisa Roberts | Head Of Business Operations | Leadership |
Charlie Wright | Associate Director - Project Management | Leadership |
Rob Halliwell | Associate Director Of Marketing | Leadership |
Michael Mellor-Clark | Chief Commercial Officer (cco) | Leadership |
Myles Terrey | Inside Sales Manager | Team |
Molly Foster | Financial Officer | Team |
Jack Lakin | Senior Scientist 1 | Team |
Naomi Allen | Senior Manufacturing Scientist II | Team |
Rebecca Gray | QC Manager | Team |
Pablo Galaz | Senior Analytical Scientist II | Team |
Katie Radford | Senior Quality Assurance Officer I | Team |
Lee Turnbull | Warehouse & Health And Safety Manager | Team |
James Gregory | Manufacturing Manager | Team |
Matthew Chillman | Principal Scientist (technical Transfer) | Team |
Complete people profiles for Upperton
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Upperton
3 dated milestones of Upperton across 23 years, from founding to its latest funding, stage changes and deals.
- Founded Upperton is founded.
- Funding First funding round of $2.6M.
- Exit Acquired by Inflexion.
Web traffic of Upperton
The website of Upperton (upperton.com) receives about 14.1K visits a month.
- Monthly visits14.1K
▲ 1.1% vs previous month
Websites whose visitors overlap most with Upperton. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| cholestech.com | 100% | View details | |||
| quidel.com | 100% | #5,902,749 | View details | ||
| dianon.com | 100% | View details | |||
miscpaper.com | miscpaper.com | 100% | #11,804,843 | – | |
sensoryarts.com | sensoryarts.com | 100% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 17 similar websites and full traffic analytics for Upperton
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 17 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Upperton
Complete news archive for Upperton
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Upperton
Upperton was founded in 1999 and raised its 1st funding round 16 years after it was founded.
Upperton is headquartered in Nottingham, United Kingdom.
Upperton was founded in 1999 and is based in Nottingham, United Kingdom. Operations focus on the pharmaceutical and biotechnology sectors, where spray drying expertise is applied to develop delivery solutions and formulations. Services encompass pre-formulation screening, excipient selection, spray drying process development, product characterization, stability assessment, and clinical trial manufacturing. Solutions address bioavailability improvement for poorly soluble drugs, particle engineering for pulmonary and nasal routes, protein stability enhancement, and microencapsulation.
Upperton offers Formulation Development, Clinical Supply, Analytical Development, and Process Scale-Up.
Upperton has 2 investors. Key investors include Inflexion, and European Union.
Upperton operates through 37 Upperton Rtm Company Limited.
Yes. Upperton was acquired by Inflexion in April 2022.